Exact Mass: 605.1264316
Exact Mass Matches: 605.1264316
Found 49 metabolites which its exact mass value is equals to given mass value 605.1264316,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Guanosine diphosphate mannose
C16H25N5O16P2 (605.0771510000001)
Guanosine diphosphate mannose, also known as gdp-D-mannose or guanosine pyrophosphoric acid mannose, is a member of the class of compounds known as purine nucleotide sugars. Purine nucleotide sugars are purine nucleotides bound to a saccharide derivative through the terminal phosphate group. Guanosine diphosphate mannose is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Guanosine diphosphate mannose can be found in a number of food items such as sorrel, common persimmon, citrus, and butternut, which makes guanosine diphosphate mannose a potential biomarker for the consumption of these food products. Guanosine diphosphate mannose exists in all living species, ranging from bacteria to humans. In humans, guanosine diphosphate mannose is involved in a couple of metabolic pathways, which include fructose and mannose degradation and fructose intolerance, hereditary. Guanosine diphosphate mannose is also involved in fructosuria, which is a metabolic disorder. Guanosine diphosphate mannose or GDP-mannose is a nucleotide sugar that is a substrate for glycosyltransferase reactions in metabolism. This compound is a substrate for enzymes called mannosyltransferases . GDP-mannose is a nucleoside diphosphate sugar that is important in the production of fucosylated oligosaccharides. In particular, GDP-mannose is converted to GDP-fucose, which is the fucose donor in the construction of all mammalian fucosylated glycans. GDP-mannose is transformed to GDP-fucose via three enzymatic reactions carried out by two proteins, GDP-mannose 4,6-dehydratase (GMD) and a second enzyme, GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase. GDP-mannose 4,6-dehydratase (EC 4.2.1.47) catalyzes the chemical reaction: GDP-mannose <--> GDP-4-dehydro-6-deoxy-D-mannose + H2O. The epimerase converts the GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose (PMID: 12651883). GDP-mannose is also synthesized from mannose 1-phosphate via the enzyme ATP-mannose-1-phosphate-guanyltransferase and GTP. Acquisition and generation of the data is financially supported in part by CREST/JST.
GDP-glucose
C16H25N5O16P2 (605.0771510000001)
Acquisition and generation of the data is financially supported in part by CREST/JST. GDP-glucose is a substrate for Uridine diphosphate glucose pyrophosphatase. [HMDB] GDP-glucose is a substrate for Uridine diphosphate glucose pyrophosphatase.
Gadobutrol
Gadobutrol is only found in individuals that have used or taken this drug.It is a contrast agent used in magnetic resonance imaging (MRI). V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media
PYRIMIDINE DERIVATIVE
diphosphoric acid-1-alpha-D-fructopyranosyl ester-2-guanosin-5-yl ester|Diphosphorsaeure-1-alpha-D-fructopyranosylester-2-guanosin-5-ylester
C16H25N5O16P2 (605.0771510000001)
Guanosindiphosphatfructose|O5-(2-beta-D-fructos-1-yloxy-1,2-dihydroxy-diphosphoryl)-guanosine
C16H25N5O16P2 (605.0771510000001)
Guanosine-5-diphosphate-D-mannose sodium salt
C16H25N5O16P2 (605.0771510000001)
Guanosine-5-diphosphoglucose sodium salt
C16H25N5O16P2 (605.0771510000001)
GUANOSINE 5,9;-DIPHOSPHO-D-MANNOSE
C16H25N5O16P2 (605.0771510000001)
Gadobutrol
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media
N-[4-amino-3-(5,10-dihydro-5,10-dioxoanthra[2,3-d]thiazol-2-yl)-9,10-dihydro-9,10-dioxo-1-anthryl]benzamide
Prochlorperazine maleate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics
chloro(di-2-norbornylphosphino)(2-dimethylaminomethylferrocen-1-yl)palladium(ii)
Guanosine 5-(trihydrogen diphosphate) P-D-mannopyranosyl ester
C16H25N5O16P2 (605.0771510000001)
Gadovist
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media
Guanosine 5-diphosphate-beta-L-gulose
C16H25N5O16P2 (605.0771510000001)
[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate
C18H29N3O16P2 (605.1023014000001)
[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
C16H25N5O16P2 (605.0771510000001)
(3E)-3-[4-amino-5-[(4-chlorophenyl)methyl]pyrimidin-2-yl]imino-5-chloro-1-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]indol-2-one
Prochlorperazine bimaleate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics
guanosine 5-[3-(L-galactopyranosyl) dihydrogen diphosphate]
C16H25N5O16P2 (605.0771510000001)
17beta-estradiol 3-O-(3-sulfo-beta-D-glucuronate) 17-sulfate
UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
C17H27N4O16P2- (605.0897262000001)
[[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
C16H25N5O16P2 (605.0771510000001)
Guanosine 5-diphosphate-D-mannose
C16H25N5O16P2 (605.0771510000001)
[[(2S,3R,4S,5S)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
C16H25N5O16P2 (605.0771510000001)
[[(2R,3S,4R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
C16H25N5O16P2 (605.0771510000001)
Gadavist
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media
GDP-D-Mannose
C16H25N5O16P2 (605.0771510000001)
A GDP-mannose in which the mannose fragment has D-configuration.
GDP-alpha-D-Mannose
C16H25N5O16P2 (605.0771510000001)
The alpha-anomer of GDP-D-mannose.
GDP-alpha-D-glucose
C16H25N5O16P2 (605.0771510000001)
A GDP-D-glucose having alpha-configuration at the anomeric centre.
Sirtuin modulator 1
Sirtuin modulator 1 is a modulator of SIRTl, a homolog of SIRT3, with EC1.5 of < 1 μM, extracted from patent WO 2010071853 A1, Compound No.4.